Vitamin E for the management of major depressive disorder: possible role of the anti-inflammatory and antioxidant systems

References

• World Health Organization. Depression and other common mental disorders: global health estimates. World Health Organization. 2017;1–24.
   Google Scholar
• Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391:1357–66.
   PubMed Web of Science ®Google Scholar
• Kaster MP, Moretti M, Cunha MP, et al. Novel approaches for the management of depressive disorders. Eur J Pharmacol. 2016;771:236–40.
   PubMed Web of Science ®Google Scholar
• Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65:732–42.
   PubMed Web of Science ®Google Scholar
• Lobato KR, Cardoso CC, Binfaré RW, et al. α-Tocopherol administration produces an antidepressant-like effect in predictive animal models of depression. Behav Brain Res. 2010;209:249–59.
   PubMed Web of Science ®Google Scholar
• Manosso LM, Neis VB, Moretti M, et al. Antidepressant-like effect of α-tocopherol in a mouse model of depressive-like behavior induced by TNF-α. Prog Neuro-Psychopharmacology Biol Psychiatry. 2013;46:48–57.
   PubMed Web of Science ®Google Scholar
• Huang X, Wu H, Jiang R, et al. The antidepressant effects of ɑ-tocopherol are related to activation of autophagy via the AMPK/mTOR pathway. Eur J Pharmacol. 2018;833:1–7.
   PubMed Web of Science ®Google Scholar
• Evans HM, Bishop KS. On the existence of a hitherto unrecognized dietary factor for reproduction. Science. 1922;56:650–51.
   PubMedGoogle Scholar
• Traber MG. Vitamin E regulatory mechanisms. Annu Rev Nutr. 2007;27:347–62.
   PubMed Web of Science ®Google Scholar
• Brigelius-Flohé R, Traber MG. Vitamin E: function and metabolism. FASEB J. 1999;13:1145–55.
   PubMed Web of Science ®Google Scholar
• Schneider C. Chemistry and biology of vitamin E. Mol Nutr Food Res. 2005;49:7–30.
   PubMed Web of Science ®Google Scholar
• Murphy P, Subar F, Block G. Vitamin E intakes and sources in the United States. Am J Clin Nutr. 1990;52:361–167.
   PubMed Web of Science ®Google Scholar
• Bramley PM, Elmadfa I, Kafatos A, et al. Vitamin E. J Sci Food Agric. 2000;80:913–38.
   Web of Science ®Google Scholar
• National Institutes of Health. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington (DC): National Academies Press; 2000.
   Google Scholar
• Gallo-Torres HE. Obligatory role of bile for the intestinal absorption of vitamin E. Lipids. 1970;5:379–84.
   PubMed Web of Science ®Google Scholar
• Traber MG, Sies H. Vitamin E in humans: demand and delivery. Annu Rev Nutr. 1996;16:321–47.
   PubMed Web of Science ®Google Scholar
• Reboul E, Klein A, Bietrix F, et al. Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte. J Biol Chem. 2006;281:4739–45.
   PubMed Web of Science ®Google Scholar
• Reboul E. Vitamin E intestinal absorption: regulation of membrane transport across the enterocyte. IUBMB Life. 2019;71:416–23.
   PubMed Web of Science ®Google Scholar
• Tucker JM, Townsend DM. Alpha-tocopherol: roles in prevention and therapy of human disease. Biomed Pharmacother. 2005;59:380–87.
   PubMed Web of Science ®Google Scholar
• Lemaire-Ewing S, Desrumaux C, Néel D, Lagrost L. Vitamin E transport, membrane incorporation and cell metabolism: is α-Tocopherol in lipid rafts an oar in the lifeboat? Mol Nutr Food Res. 2010;54:631–40.
   PubMed Web of Science ®Google Scholar
• Ricciarelli R, Zingg JM, Azzi A. (2001). Vitamin E 80th anniversary: a double life, not only fighting radicals. In: IUBMB Life. IUBMB Life, pp 71–76.
   Google Scholar
• Goti D, Hammer A, Galla HJ, et al. Uptake of lipoprotein-associated α-tocopherol by primary porcine brain capillary endothelial cells. J Neurochem. 2000;74:1374–83.
   PubMed Web of Science ®Google Scholar
• Goti D, Hrzenjak A, Levak-Frank S, et al. Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL-associated vitamin E. J Neurochem. 2001;76:498–508.
   PubMed Web of Science ®Google Scholar
• Lee P, Ulatowski LM. Vitamin E: mechanism of transport and regulation in the CNS. IUBMB Life. 2019;71:424–29.
   PubMed Web of Science ®Google Scholar
• Olivier M, Bott R, Frisdal E, et al. ABCG1 is involved in vitamin E efflux. BBA-Mol Cell Biol L. 2014;1841:1741–51.
   Google Scholar
• Gotoda T, Arita M, Arai H, et al. Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the alpha-tocopherol–transfer protein. N Engl J Med. 1995;333:1313–19.
   PubMed Web of Science ®Google Scholar
• Gohil K, Oommen S, Quach HT, et al. Mice lacking α-tocopherol transfer protein gene have severe α-tocopherol deficiency in multiple regions of the central nervous system. Brain Res. 2008;1201:167–76.
   PubMed Web of Science ®Google Scholar
• Muller DPR. Vitamin E and neurological function. Mol Nutr Food Res. 2010;54:710–18.
   PubMed Web of Science ®Google Scholar
• Saremi A, Arora R. Vitamin E and cardiovascular disease. Am J Ther. 2010;17:56–65.
   PubMed Web of Science ®Google Scholar
• Ortega RM, Requejo AM, Ló Pez-Sobaler AM, et al. Cognitive function in elderly people is influenced by vitamin E status. J Nutr. 2002;132:2065–68.
   PubMed Web of Science ®Google Scholar
• Takatsu H, Owada K, Abe K, et al. Effect of vitamin E on learning and memory deficit in aged rats. J Nutr Sci Vitaminol. 2009;55:389–93.
   PubMed Web of Science ®Google Scholar
• Comin D, Gazarini L, Zanoni JN, et al. Vitamin E improves learning performance and changes the expression of nitric oxide-producing neurons in the brains of diabetic rats. Behav Brain Res. 2010;210:38–45.
   PubMed Web of Science ®Google Scholar
• Sung S, Yao Y, Uryu K, et al. Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer’s disease. FASEB J. 2004;18:323–25.
   PubMed Web of Science ®Google Scholar
• Rota C, Rimbach G, Minihane AM, et al. Dietary vitamin E modulates differential gene expression in the rat hippocampus: potential implications for its neuroprotective properties. Nutr Neurosci. 2005;8:21–29.
   PubMed Web of Science ®Google Scholar
• Mangialasche F, Kivipelto M, Mecocci P, et al. High plasma levels of vitamin E forms and reduced Alzheimer’s disease risk in advanced age. J Alzheimer’s Dis. 2010;20:1029–37.
   PubMed Web of Science ®Google Scholar
• Dong Y, Chen X, Liu Y, et al. Do low-serum vitamin E levels increase the risk of Alzheimer disease in older people? Evidence from a meta-analysis of case-control studies. Int J Geriatr Psychiatry. 2018;33:257–63.
   PubMed Web of Science ®Google Scholar
• Rutjes AWS, Denton DA, Di Nisio M, et al. Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life. Cochrane Database Syst Rev. 2018;12:CD011906.
   PubMedGoogle Scholar
• Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352:2379–88.
   PubMed Web of Science ®Google Scholar
• Férnandez-Calle P, Molina JA, Jiménez-Jiménez FJ, et al. Serum levels of alpha-tocopherol (vitamin E) in Parkinson’s disease. Neurology. 1992;42:1064–66.
   PubMed Web of Science ®Google Scholar
• King D, Playfer JR, Roberts NB. Concentrations of vitamins A, C and E in elderly patients with Parkinson’s disease. Postgrad Med J. 1992;68:634–37.
   PubMedGoogle Scholar
• Molina JA, De Bustos F, Jiménez-Jiniénez FJ, et al. Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Parkinson’s disease. J Neural Transm. 1997;104:1287–93.
   PubMed Web of Science ®Google Scholar
• Nicoletti G, Crescibene L, Scornaienchi M, et al. Plasma levels of vitamin E in Parkinson’s disease. Arch Gerontol Geriatr. 2001;33:7–12.
   PubMed Web of Science ®Google Scholar
• Schirinzi T, Martella G, Imbriani P, et al. Dietary vitamin E as a protective factor for Parkinson’s disease: clinical and experimental evidence. Front Neurol. 2019;10:1–7.
   PubMed Web of Science ®Google Scholar
• Pasbakhsh P, Omidi N, Mehrannia K, et al. The protective effect of vitamin E on locus coeruleus in early model of Parkinson’s disease in rat: immunoreactivity evidence. Iran Biomed J. 2008;12:217–22.
   PubMedGoogle Scholar
• Ambrogini P, Betti M, Galati C, et al. α-tocopherol and hippocampal neural plasticity in physiological and pathological conditions. Int J Mol Sci. 2016;17:1–32.
   Web of Science ®Google Scholar
• Ferri P, Cecchini T, Ciaroni S, et al. Vitamin E affects cell death in adult rat dentate gyrus. J Neurocytol. 2003;32:1155–1164.
   PubMedGoogle Scholar
• Cuppini R, Ciaroni S, Cecchini T, et al. α-Tocopherol controls cell proliferation in the adult rat dentate gyrus. Neurosci Lett. 2001;303:198–200.
   PubMed Web of Science ®Google Scholar
• Cuppini R, Ciaroni S, Cecchini T, et al. Tocopherols enhance neurogenesis in dentate gyrus of adult rats. Int J Vitam Nutr Res. 2002;72:170–76.
   PubMed Web of Science ®Google Scholar
• Desrumaux C, Risold P-Y, Schroeder H, et al. Phospholipid transfer protein (PLTP) deficiency reduces brain vitamin E content and increases anxiety in mice. FASEB J. 2005;19:1–16.
   PubMedGoogle Scholar
• Hughes RN, Collins MA. Enhanced habituation and decreased anxiety by environmental enrichment and possible attenuation of these effects by chronic α-tocopherol (vitamin E) in aging male and female rats. Pharmacol Biochem Behav. 2010;94:534–42.
   PubMed Web of Science ®Google Scholar
• Desrumaux CM, Mansuy M, Lemaire S, et al. Brain vitamin E deficiency during development is associated with increased glutamate levels and anxiety in adult mice. Front Behav Neurosci. 2018;12:1–7.
   PubMed Web of Science ®Google Scholar
• Ataei-Almanghadim K, Farshbaf-Khalili A, Ostadrahimi AR, et al. The effect of oral capsule of curcumin and vitamin E on the hot flashes and anxiety in postmenopausal women: a triple blind randomised controlled trial. Complement Ther Med. 2020;48:102267.
   PubMed Web of Science ®Google Scholar
• Maes M, De Vos N, Pioli R, et al. Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. J Affect Disord. 2000;58:241–246.
   PubMed Web of Science ®Google Scholar
• Owen AJ, Batterham MJ, Probst YC, et al. Low plasma vitamin E levels in major depression: diet or disease? Eur J Clin Nutr. 2005;59:304–306.
   PubMed Web of Science ®Google Scholar
• Banikazemi Z, Mokhber N, Safarian M, et al. Dietary vitamin E and fat intake are related to Beck’s depression score. Clin Nutr ESPEN. 2015;10:61–65.
   PubMed Web of Science ®Google Scholar
• Parveen T, Nazi B, Amin N, Haleem DJ. Repeated administration of vitamin E decreases 5HIAA levels producing antidepressant effect and enhance behavioural effects. Pakistan J Biochem Mol Biol. 2010;43:169–73.
   Google Scholar
• Kappus H, Diplock AT. Tolerance and safety of vitamin E: a toxicological position report. Free Radic Biol Med. 1992;13:55–74.
   PubMed Web of Science ®Google Scholar
• Bendich A, Machlin L. Safety of oral intake of vitamin E. Am J Clin Nutr. 1988;48:612–19.
   PubMed Web of Science ®Google Scholar
• Otte C, Gold S, Penninx B, et al. Major depressive disorder. Nat Rev. 2016;2:1–20.
   Google Scholar
• Lépine JP, Briley M. The increasing burden of depression. Neuropsychiatr Dis Treat. 2011;7:3–7.
   PubMedGoogle Scholar
• Martin-Subero M, Anderson G, Kanchanatawan B, et al. Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress, tryptophan catabolite, and gut-brain pathways. CNS Spectr. 2016;21:184–198.
   PubMed Web of Science ®Google Scholar
• Hirschfeld RMA. History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry. 2000;61:4–6.
   PubMed Web of Science ®Google Scholar
• Delgado PL. Depression: the case for a monoamine deficiency. J Clin Psychiatry. 2000;61:7–11.
   PubMed Web of Science ®Google Scholar
• Duman RS. Neural plasticity: consequences of stress and actions of antidepressant treatment. Dialogues Clin Neurosci. 2004;6:157–169.
   PubMedGoogle Scholar
• Duman RS, Li N. A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists. Philos Trans R Soc B Biol Sci. 2012;367:2475–84.
   PubMed Web of Science ®Google Scholar
• Maes M, Yirmyia R, Noraberg J, et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis. 2009;24:27–53.
   PubMed Web of Science ®Google Scholar
• Rawdin BJ, Mellon SH, Dhabhar FS, et al. Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behav Immun. 2013;31:143–52.
   PubMed Web of Science ®Google Scholar
• Iob E, Kirschbaum C, Steptoe A. Persistent depressive symptoms, HPA-axis hyperactivity, and inflammation: the role of cognitive-affective and somatic symptoms. Mol Psychiatry. 2020;25:1130–40.
   PubMed Web of Science ®Google Scholar
• Watson S, Mackin P. HPA axis function in mood disorders. Psychiatry. 2006;5:166–70.
   Google Scholar
• Ng F, Berk M, Dean O, Bush AI. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol. 2008;11:851–76.
   PubMed Web of Science ®Google Scholar
• Maes M, Galecki P, Chang YS, Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuro-Psychopharmacology Biol Psychiatry. 2011;35:676–92.
   PubMed Web of Science ®Google Scholar
• Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408:239–247.
   PubMed Web of Science ®Google Scholar
• Ricciarelli R, Argellati F, Pronzato MA, Domenicotti C. Vitamin E and neurodegenerative diseases. Mol Aspects Med. 2007;28:591–606.
   PubMed Web of Science ®Google Scholar
• Pizzino G, Irrera N, Cucinotta M, et al. Oxidative stress: harms and benefits for human health. Hindawi. 2017;17:1–13.
   Google Scholar
• Halliwell B. Oxidative stress and neurodegeneration: where are we now? J Neurochem. 2006;97:1634–58.
   PubMed Web of Science ®Google Scholar
• Salim S. Oxidative stress and the central nervous system. J Pharmacol Exp Ther. 2017;360:201–205.
   PubMed Web of Science ®Google Scholar
• Dringen R, Hirrlinger J. Glutathione pathways in the brain. Biol Chem. 2003;384:505–16.
   PubMed Web of Science ®Google Scholar
• Bajpai A, Verma AK, Srivastava M, Srivastava R. Oxidative stress and major depression. J Clin Diagnostic Res. 2014;8:4–7.
   Google Scholar
• Michel TM, Pulschen D, Thome J. The role of oxidative stress in depressive disorders. Curr Pharm Des. 2012;18:5890–99.
   PubMed Web of Science ®Google Scholar
• Anderson G, Maes M. Oxidative/nitrosative stress and immuno-inflammatory pathways in depression: treatment implications. Curr Pharm Des. 2014;20:3812–47.
   PubMed Web of Science ®Google Scholar
• Bilici M, Efe H, Köroğlu MA, et al. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord. 2001;64:43–51.
   PubMed Web of Science ®Google Scholar
• Yanik M, Erel O, Kati M. The relationship between potency of oxidative stress and severity of depression. Acta Neuropsychiatr. 2004;16:200–203.
   PubMed Web of Science ®Google Scholar
• Tsuboi H, Shimoi K, Kinae N, et al. Depressive symptoms are independently correlated with lipid peroxidation in a female population: comparison with vitamins and carotenoids. J Psychosom Res. 2004;56:53–58.
   PubMed Web of Science ®Google Scholar
• Sarandol A, Sarandol E, Eker SS, et al. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative – antioxidative systems. Hum Psychopharmacol. 2007;22:67–73.
   PubMed Web of Science ®Google Scholar
• Moretti M, Colla A, De Oliveira Balen G, et al. Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress. J Psychiatr Res. 2012;46:331–340.
   PubMed Web of Science ®Google Scholar
• Zeni ALB, Camargo A, Dalmagro AP. Lutein prevents corticosterone-induced depressive-like behavior in mice with the involvement of antioxidant and neuroprotective activities. Pharmacol Biochem Behav. 2019;179:63–72.
   PubMed Web of Science ®Google Scholar
• Camargo A, Dalmagro AP, Rikel L, et al. Cholecalciferol counteracts depressive-like behavior and oxidative stress induced by repeated corticosterone treatment in mice. Eur J Pharmacol. 2018;833:451–61.
   PubMed Web of Science ®Google Scholar
• Freitas AE, Egea J, Buendia I, et al. Agmatine, by improving neuroplasticity markers and inducing Nrf2, prevents corticosterone-induced depressive-like behavior in mice. Mol Neurobiol. 2016;53:3030–3045.
   PubMed Web of Science ®Google Scholar
• Black CN, Bot M, Scheffer PG, Penninx BWJH. Oxidative stress in major depressive and anxiety disorders, and the association with antidepressant use: results from a large adult cohort. Psychol Med. 2017;47:936–948.
   PubMed Web of Science ®Google Scholar
• Herken H, Gurel A, Selek S, et al. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res. 2007;38:247–252.
   PubMed Web of Science ®Google Scholar
• Liu T, Zhong S, Liao X, et al. A meta-analysis of oxidative stress markers in depression. PLoS One. 2015;10:e0138904.
   PubMed Web of Science ®Google Scholar
• Behr GA, Moreira JCF, Frey BN. Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder. Oxid Med Cell Longev. 2012;12:1–13.
   Google Scholar
• Maes M. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuroendocrinol Lett. 2008;29:287–91.
   PubMed Web of Science ®Google Scholar
• Haroon E, Miller AH, Sanacora G. Inflammation, glutamate, and glia: a trio of trouble in mood disorders. Neuropsychopharmacology. 2017;42:193–215.
   PubMed Web of Science ®Google Scholar
• Krishnadas R, Cavanagh J. Depression: an inflammatory illness? J Neurol Neurosurg Psychiatry. 2012;83:495–502.
   PubMed Web of Science ®Google Scholar
• Einvik G, Vistnes M, Hrubos-Strøm H, et al. Circulating cytokine concentrations are not associated with major depressive disorder in a community-based cohort. Gen Hosp Psychiatry. 2012;34:262–67.
   PubMed Web of Science ®Google Scholar
• Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67:446–457.
   PubMed Web of Science ®Google Scholar
• Dhabhar FS, Burke HM, Epel ES, et al. Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression. J Psychiatr Res. 2009;43:962–69.
   PubMed Web of Science ®Google Scholar
• Zou W, Feng R, Yang Y. Changes in the serum levels of inflammatory cytokines in antidepressant drug-naïve patients with major depression. PLoS One. 2018;13:e0197267.
   PubMed Web of Science ®Google Scholar
• Myint AM, Schwarz MJ, Steinbusch HWM, Leonard BE. Neuropsychiatric disorders related to interferon and interleukins treatment. Metab Brain Dis. 2009;24:55–68.
   PubMed Web of Science ®Google Scholar
• Jansen R, Penninx BWJH, Madar V, et al. Gene expression in major depressive disorder. Mol Psychiatry. 2016;21:339–47.
   PubMed Web of Science ®Google Scholar
• Cassidy-Bushrow AE, Peters RM, Johnson DA, Templin TN. Association of depressive symptoms with inflammatory biomarkers among pregnant African-American women. J Reprod Immunol. 2012;94:202–209.
   PubMed Web of Science ®Google Scholar
• Howren MB, Lamkin DM, Suls J. Associations of depression with c-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71:171–86.
   PubMed Web of Science ®Google Scholar
• Smith KJ, Au B, Ollis L, Schmitz N. The association between C-reactive protein, Interleukin-6 and depression among older adults in the community: a systematic review and meta-analysis. Exp Gerontol. 2018;102:109–132.
   PubMed Web of Science ®Google Scholar
• Haapakoski R, Mathieu J, Ebmeier KP, et al. Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain Behav Immun. 2015;49:206–15.
   PubMed Web of Science ®Google Scholar
• Jun T-Y, Pae C-U, Chae J-H, et al. Tumor necrosis factor-beta gene polymorphism may not be associated with major depressive disorder in the Korean population. Psychiatry Clin Neurosci. 2003;57:31–35.
   PubMed Web of Science ®Google Scholar
• Fertuzinhos SMM, Oliveira JRM, Nishimura AL, et al. Analysis of IL-1α, IL-1β, and IL-RA polymorphisms in dysthymia. J Mol Neurosci. 2004;22:251–55.
   PubMed Web of Science ®Google Scholar
• Ping F, Shang J, Zhou J, et al. 5-HT1A receptor and apoptosis contribute to interferon-α-induced “ depressive-like” behavior in mice. Neurosci Lett. 2012;514:173–178.
   PubMed Web of Science ®Google Scholar
• Kaster MP, Gadotti VM, Calixto JB, et al. Depressive-like behavior induced by tumor necrosis factor-α in mice. Neuropharmacology. 2012;62:419–26.
   PubMed Web of Science ®Google Scholar
• Kenis G, Maes M. Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol. 2002;5:401–12.
   PubMed Web of Science ®Google Scholar
• Nishida A, Hisaoka K, Zensho H, et al. Antidepressant drugs and cytokines in mood disorders. Int Immunopharmacol. 2002;2:1619–26.
   PubMed Web of Science ®Google Scholar
• Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology. 2000;22:370–79.
   PubMed Web of Science ®Google Scholar
• Maes M, Song C, Lin AH, et al. Negative immunoregulatory effects of antidepressants inhibition of interferon-γ and stimulation of interleukin-10 secretion. Neuropsychopharmacology. 1999;20:370–79.
   PubMed Web of Science ®Google Scholar
• Tuglu C, Kara SH, Caliyurt O, et al. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology. 2003;170:429–33.
   PubMed Web of Science ®Google Scholar
• Munzer A, Sack U, Mergl R, et al. Impact of antidepressants on cytokine production of depressed patients in vitro. Toxins. 2013;5:2227–40.
   PubMed Web of Science ®Google Scholar
• Singh U, Devaraj S, Jialal I. Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr. 2005;25:151–174.
   PubMed Web of Science ®Google Scholar
• Herrera E, Barbas C. Vitamin E: action, metabolism and perspectives. J Physiol Biochem. 2001;57:43–56.
   PubMed Web of Science ®Google Scholar
• Shinde SN, Dhadke VN, Suryakar AN. Evaluation of oxidative stress in type 2 diabetes mellitus and follow-up along with vitamin E supplementation. Indian J Clin Biochem. 2011;26:74–77.
   PubMedGoogle Scholar
• Zal F, Mostafavi-Pour Z, Amini F, Heidari A. Effect of vitamin E and C supplements on lipid peroxidation and GSH-dependent antioxidant enzyme status in the blood of women consuming oral contraceptives. Contraception. 2012;86:62–66.
   PubMed Web of Science ®Google Scholar
• Aghadavod E, Soleimani A, Hamidi G, et al. Effects of high-dose vitamin E supplementation on markers of cardiometabolic risk and oxidative stress in patients with diabetic nephropathy: a randomized double-blinded controlled trial. Iran J Kidney Dis. 2018;12:156–162.
   PubMed Web of Science ®Google Scholar
• Tantavisut S, Tanavalee A, Honsawek S, et al. Effect of vitamin E on oxidative stress level in blood, synovial fluid, and synovial tissue in severe knee osteoarthritis: A randomized controlled study. BMC Musculoskelet Disord. 2017;18:1–9.
   PubMedGoogle Scholar
• Guertin KA, Grant RK, Arnold KB, et al. Effect of long-term vitamin E and selenium supplementation on urine F2-isoprostanes, a biomarker of oxidative stress. Free Radic Biol Med. 2016;95:349–56.
   PubMed Web of Science ®Google Scholar
• Khatami PG, Soleimani A, Sharifi N, et al. The effects of high-dose vitamin E supplementation on biomarkers of kidney injury, inflammation, and oxidative stress in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial. J Clin Lipidol. 2016;10:922–29.
   PubMed Web of Science ®Google Scholar
• Niki E. Evidence for beneficial effects of vitamin E. Korean J Intern Med. 2015;30:571–79.
   PubMed Web of Science ®Google Scholar
• Traber MG, Atkinson J. Vitamin E, antioxidant and nothing more. Free Radic Biol Med. 2007;43:4–15.
   PubMed Web of Science ®Google Scholar
• Behl C. Vitamin E protects neurons against oxidative cell death in vitro more effectively than 17-β estradiol and induces the activity of the transcription factor NF-κB. J Neural Transm. 2000;107:393–407.
   PubMed Web of Science ®Google Scholar
• Beytut E, Yilmaz S, Aksakal M, Polat S. The possible protective effects of vitamin E and selenium administration in oxidative stress caused by high doses of glucocorticoid administration in the brain of rats. J Trace Elem Med Biol. 2018;45:131–35.
   PubMed Web of Science ®Google Scholar
• Arai M, Saito M, Takatsu H, et al. Dysfunction of the fusion of pre-synaptic plasma membranes and synaptic vesicles caused by oxidative stress, and its prevention by vitamin E. J Alzheimer’s Dis. 2011;24:759–66.
   PubMed Web of Science ®Google Scholar
• Lewis ED, Meydani SN, Wu D. Regulatory role of vitamin E in the immune system and inflammation. IUBMB Life. 2019;71:487–94.
   PubMed Web of Science ®Google Scholar
• Smolarek AK, So JY, Thomas PE, et al. Dietary tocopherols inhibit cell proliferation, regulate expression of ERα, PPARγ, and Nrf2, and decrease serum inflammatory markers during the development of mammary hyperplasia. Mol Carcinog. 2013;52:514–25.
   PubMed Web of Science ®Google Scholar
• Yam ML, Abdul Hafid SR, Cheng HM, Nesaretnam K. Tocotrienols suppress proinflammatory markers and cyclooxygenase-2 expression in RAW264.7 macrophages. Lipids. 2009;44:787–97.
   PubMed Web of Science ®Google Scholar
• Devaraj S, Tang R, Adams-Huet B, et al. Effect of high-dose α-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. Am J Clin Nutr. 2007;86:1392–1398.
   PubMed Web of Science ®Google Scholar
• Devaraj S, Jialal I. Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radic Biol Med. 2000;29:790–92.
   PubMed Web of Science ®Google Scholar
• Pein H, Ville A, Pace S, et al. Endogenous metabolites of vitamin E limit inflammation by targeting 5-lipoxygenase. Nat Commun. 2018;9:3834.
   PubMed Web of Science ®Google Scholar
• Godbout JP, Berg BM, Krzyszton C, Johnson RW. α-Tocopherol attenuates NFκB activation and pro-inflammatory cytokine production in brain and improves recovery from lipopolysaccharide- induced sickness behavior. J Neuroimmunol. 2005;169:97–105.
   PubMed Web of Science ®Google Scholar
• Godbout JP, Berg BM, Kelley KW, Johnson RW. α-tocopherol reduces lipopolysaccharide-induced peroxide radical formation and interleukin-6 secretion in primary murine microglia and in brain. J Neuroimmunol. 2004;149:101–109.
   PubMed Web of Science ®Google Scholar
• Ranard KM, Kuchan MJ, Erdman JW. α-Tocopherol, but not γ-tocopherol, attenuates the expression of selective tumor necrosis factor-alpha-induced genes in primary human aortic cell lines. Lipids. 2019;54:289–99.
   PubMed Web of Science ®Google Scholar
• Cadenas S, Cadenas AM. Fighting the stranger – antioxidant protection against endotoxin toxicity. Toxicology. 2002;180:45–63.
   PubMed Web of Science ®Google Scholar
• Reiter E, Jiang Q, Christen S. Anti-inflammatory properties of α- and γ-tocopherol. Mol Aspects Med. 2007;28:668–691.
   PubMed Web of Science ®Google Scholar
• Wu D, Meydani SN. Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention. J Leukoc Biol. 2008;84:900–14.
   PubMed Web of Science ®Google Scholar
• Shibata H, Kumagai S, Watanabe S, Suzuki T. Relationship of serum cholesterols and vitamin E to depressive status in the elderly. J Epidemiol. 1999;9:261–67.
   PubMedGoogle Scholar
• Tiemeier H, Hofman A, Kiliaan AJ, et al. Vitamin E and depressive symptoms are not related. The Rotterdam Study. J Affect Disord. 2002;72:79–83.
   PubMed Web of Science ®Google Scholar
• Tsuboi H, Tatsumi A, Yamamoto K, et al. Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants. J Affect Disord. 2006;91:63–70.
   PubMed Web of Science ®Google Scholar
• Capuron L, Moranis A, Combe N, et al. Vitamin E status and quality of life in the elderly: influence of inflammatory processes. Br J Nutr. 2009;102:1390–94.
   PubMed Web of Science ®Google Scholar
• German L, Kahana C, Rosenfeld V, et al. Depressive symptoms are associated with food insufficiency and nutritional deficiencies in poor community-dwelling elderly people. J Nutr Heal Aging. 2011;15:3–8.
   PubMed Web of Science ®Google Scholar
• Rubio-López N, Morales-Suárez-Varela M, Pico Y, et al. Nutrient intake and depression symptoms in Spanish children: the ANIVA study. Int J Environ Res Public Health. 2016;13:352.
   Web of Science ®Google Scholar
• Jamilian M, Shojaei A, Samimi M, et al. The effects of omega-3 and vitamin E co-supplementation on parameters of mental health and gene expression related to insulin and inflammation in subjects with polycystic ovary syndrome. J Affect Disord. 2018;229:41–47.
   PubMed Web of Science ®Google Scholar
• Bahrami A, Khorasanchi Z, Sadeghnia HR, et al. Depression in adolescent girls: relationship to serum vitamins A and E, immune response to heat shock protein 27 and systemic inflammation. J Affect Disord. 2019;252:68–73.
   PubMed Web of Science ®Google Scholar
• Das A, Cumming RG, Naganathan V, et al. The association between antioxidant intake, dietary pattern and depressive symptoms in older Australian men: the concord health and ageing in men project. Eur J Nutr. 2020;8:1–12.
   Google Scholar
• Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology. 1985;85:367–70.
   PubMed Web of Science ®Google Scholar
• Porsolt RD, Le Pichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature. 1977;266:730–32.
   PubMed Web of Science ®Google Scholar
• Herbet M, Izdebska M, Piątkowska-Chmiel I, et al. α-tocopherol ameliorates redox equilibrium and reduces inflammatory response caused by chronic variable stress. Biomed Res Int. 2018;2018:1–12.
   Web of Science ®Google Scholar
• Papakostas GI, Ionescu DF. Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder. Mol Psychiatry. 2015;20:1142–50.
   PubMed Web of Science ®Google Scholar